Janssen Research & Development, Llc
Clinical trials sponsored by Janssen Research & Development, Llc, explained in plain language.
-
New hope for myeloma: Head-to-Head trial of two powerful drugs
Disease control Not yet recruitingThis phase 3 study tests whether a new drug, JNJ-79635322, works better than the current treatment teclistamab for people with multiple myeloma that has come back or stopped responding to prior therapies. About 700 adults who have already tried 1 to 3 treatments, including specif…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 09, 2026 05:34 UTC
-
Head-to-Head drug battle aims to tame Crohn's Flare-Ups
Disease control Not yet recruitingThis study tests whether guselkumab works better than risankizumab for people with moderate-to-severe Crohn's disease, a condition that causes long-term gut inflammation. About 530 adults will receive one of the two drugs and be followed for a year. The main goal is to see who ac…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New study tracks IBD drug persistence in saudi patients
Disease control Not yet recruitingThis study will follow 100 adults with moderate to severe Crohn's disease or ulcerative colitis in Saudi Arabia to see how long they continue taking guselkumab. Researchers want to understand real-world treatment patterns and early symptom improvements. The study does not test a …
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 05, 2026 11:56 UTC